Amy Hay Receives Two-Year Suspension After Arbitration Hearing
01:05, Sunday, 05 November, 2017
On Tuesday, Amy Hay, one of the top U.S. Olympic Weightlifters, received a two-year suspension for failing an in-competition drug test at the USA Weightlifting (USAW) American Open Series I competition in March 2017. Hay tested positive for Ostarine, a Selective Androgen Receptor Modulator (SARM), which is prohibited by the United States Anti-Doping Association (USADA) and the World Anti-Doping Association (WADA). The case was taken to arbitration where the American Arbitration Association (AAA) held hearings to make a final ruling. The sanction was announced on USADA’s website along with the arbitration ruling.